Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.
about
Current status and perspectives of patient-derived xenograft models in cancer research.Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient-Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice.Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse modelTumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo modelsHigh-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.On the role of classical and novel forms of vitamin D in melanoma progression and management.Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug.Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols.MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX)Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice.Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology.A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model.Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Cancer Orthotopic Mouse Model.Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase.Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapEngineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: Decoy, trap and kill chRegorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.CKS1 expression in melanocytic nevi and melanoma.Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella.Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model.Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.
P2860
Q33667686-4B3BCF25-C502-42A8-86BA-2956FF70C802Q33829258-D2F04004-476D-4FC0-A1F2-EB48CF9D8DE2Q36310211-C30A82DF-7D7A-4EDE-A5DB-DE44C35237A8Q37687695-AE851CD9-3E9A-4122-A88A-9995B646DF83Q37699156-B41DCD5F-D111-4BBC-80DD-A629095ECEA3Q37706071-BF82CBBE-752E-4172-889D-B9E23736C50BQ37745932-20AB8B33-8F5B-4FC4-98F8-D9BC30B385CFQ38662850-99F0DD3B-529E-4284-98FB-AB68014BC41FQ39057954-5D6AF509-84C0-45F8-8DE0-42A7F141DD21Q40163572-77102BBE-4529-43D3-BA6C-C5621ADD2A4EQ41200217-951A622C-AF8B-4909-9CF8-798DA5C6BABFQ41471129-C5920737-452D-4926-83E1-7350764B148FQ41551244-FB3E4C09-09C4-43DF-8616-5510D050D21DQ41661119-637BFDAE-7C06-48D9-9B3B-20D24F28AC76Q42139483-936881C4-AF7A-4946-9EE3-4CC1CB7ECD58Q42362667-48DB36EB-F856-42E5-871B-2B5FC5026086Q43071116-7074E028-D09A-47EB-9C3C-6B0A864BE8B0Q44144608-45ED8339-8FC1-451B-9D79-154B5930EC75Q44538901-CFEDD854-0406-44E0-9103-8DD91D6BF639Q46020823-C301C2D0-5606-447B-A3FE-54C30393DD48Q46023921-CC8278EA-CD72-4C2B-9D7F-3591966E26C1Q46115870-7B0693EE-5FDB-4983-AF6D-C2F600E800E3Q46142258-E65D3069-8BF2-4205-8D3D-46BE4D5D7048Q46198099-658BAE50-F836-45BE-97CB-112AF7F32225Q46314062-954DB3B5-A28D-4DBE-94E1-DA678B53A02EQ46326758-990E3759-18D1-452C-BBBB-E364DBDDAC64Q46341637-04E16B8D-8D36-4073-BDC3-647E1485D0DDQ46416035-44EFD16E-8B02-4155-A25C-88B04D8E5916Q46417828-6F15DFD7-72EC-4362-A2B1-3B925AA7BDE6Q46560568-FA7A3A26-018A-4B22-92AA-36CFE926321AQ47105755-0526F7F8-2DAD-47B6-A8E6-BF7D2075CDC5Q47195461-D6FBF14E-7033-42E7-8BCB-929B5578176DQ48135854-E8B9F0B4-582B-4134-95B1-41D29519701CQ48156221-24E9D341-F4A2-470B-9AAB-929CD632D286Q48243511-74B08295-8F73-445E-9EA6-5614F8DFA26FQ49185022-A82D8AC6-9455-4DF5-8E40-FF245607D2A8Q49738986-708F43A3-A1A0-436D-A584-3694AF436BDDQ50317370-BADAE10B-8C3B-420B-8929-34B0A4FB2ACEQ50328960-C34A0590-7A43-4A71-AF24-FA326D38DFD4Q50333648-297F2B73-5856-4E1D-A4BA-2CBED80E80FB
P2860
Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@ast
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@en
type
label
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@ast
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@en
prefLabel
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@ast
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@en
P2093
P2860
P1433
P1476
Efficacy of Tumor-Targeting Sa ...... graft (PDOX) Nude-Mouse Model.
@en
P2093
Elizabeth Shurell
Fritz C Eilber
Mako Yamamoto
Makoto Noda
Michael Bouvet
Robert M Hoffman
Yong Zhang
Yukihiko Hiroshima
P2860
P304
P356
10.1371/JOURNAL.PONE.0160882
P407
P577
2016-08-08T00:00:00Z